110 related articles for article (PubMed ID: 8101579)
1. Graves' ophthalmopathy and the TSH receptor.
Franklyn JA
Lancet; 1993 Aug; 342(8867):318-9. PubMed ID: 8101579
[No Abstract] [Full Text] [Related]
2. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
[TBL] [Abstract][Full Text] [Related]
3. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy.
Paschke R; Vassart G; Ludgate M
Clin Endocrinol (Oxf); 1995 Jun; 42(6):565-9. PubMed ID: 7634495
[No Abstract] [Full Text] [Related]
4. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.
Wu SL; Yang CS; Wang HJ; Liao CL; Chang TJ; Chang TC
J Endocrinol Invest; 1999 Apr; 22(4):289-95. PubMed ID: 10342363
[TBL] [Abstract][Full Text] [Related]
5. Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?
Bahn RS
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):287-96, vi. PubMed ID: 10874530
[TBL] [Abstract][Full Text] [Related]
6. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue.
Feliciello A; Porcellini A; Ciullo I; Bonavolontà G; Avvedimento EV; Fenzi G
Lancet; 1993 Aug; 342(8867):337-8. PubMed ID: 8101586
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin.
Bahn RS; Dutton CM; Joba W; Heufelder AE
Thyroid; 1998 Feb; 8(2):193-6. PubMed ID: 9510130
[TBL] [Abstract][Full Text] [Related]
8. Immunology of Graves' ophthalmopathy.
Heufelder AE; Spitzweg C
Dev Ophthalmol; 1999; 30():24-38. PubMed ID: 10627914
[No Abstract] [Full Text] [Related]
9. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
[TBL] [Abstract][Full Text] [Related]
10. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy.
Bahn RS; Dutton CM; Heufelder AE; Sarkar G
J Clin Endocrinol Metab; 1994 Feb; 78(2):256-60. PubMed ID: 7508946
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
Bahn RS
Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
[TBL] [Abstract][Full Text] [Related]
12. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy.
Heufelder AE; Dutton CM; Sarkar G; Donovan KA; Bahn RS
Thyroid; 1993; 3(4):297-300. PubMed ID: 7509671
[TBL] [Abstract][Full Text] [Related]
13. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
Prabhakar BS; Bahn RS; Smith TJ
Endocr Rev; 2003 Dec; 24(6):802-35. PubMed ID: 14671007
[TBL] [Abstract][Full Text] [Related]
14. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
[TBL] [Abstract][Full Text] [Related]
16. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
17. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy.
Heufelder AE
Thyroid; 1995 Aug; 5(4):331-40. PubMed ID: 7488878
[TBL] [Abstract][Full Text] [Related]
20. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
